Disc Medicine, Inc. - Common Stock (NQ:IRON)

80.27 -2.57 (-3.10%)

Delayed Quote Updated: 3:01 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Disc Medicine, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

December 06, 2025

From Disc Medicine Inc

Via GlobeNewswire

Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock ↗

November 19, 2025

Bain Capital completely exited its position in Disc Medicine stock during the third quarter

Via The Motley Fool

Disc Medicine Inc (NASDAQ:IRON) Reports Wider-Than-Expected Q3 2025 Loss Amid Pipeline Advancements ↗

November 06, 2025

Disc Medicine reported a wider Q3 2025 loss but advanced its bitopertin NDA with FDA priority review, targeting a 2025/2026 launch.

Via Chartmill

Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update

November 06, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

November 03, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine to Participate in Upcoming Investor Conferences

October 31, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

October 21, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

October 20, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones

October 20, 2025

From Disc Medicine Inc

Via GlobeNewswire

Top stock movements in today's session. ↗

October 17, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings ↗

October 17, 2025

Via Benzinga

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗

October 17, 2025

Via Benzinga

Which stocks are gapping on Friday? ↗

October 17, 2025

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗

October 17, 2025

The Commissioner's National Priority Review vouchers aims to speed up the review process to just one to two months.

Via Investor's Business Daily

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗

October 17, 2025

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions.

Via Benzinga

Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week

October 17, 2025

From Disc Medicine Inc

Via GlobeNewswire

Discover the top movers in Friday's pre-market session. ↗

October 17, 2025

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 17, 2025

Via Benzinga

Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗

October 17, 2025

The FDA’s new National Priority Voucher pilot helps with faster drug reviews, cutting timelines from nearly a year to weeks.

Via Stocktwits

Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)

October 16, 2025

From Disc Medicine Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 16, 2025

Via Benzinga

Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides

October 14, 2025

As of mid-October 2025, a compelling and diverse group of companies, spanning utilities, biotechnology, advanced materials, and defense, have seen their stocks reach impressive 52-week highs. This...

Via MarketMinute

Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)

September 30, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine to Participate in Upcoming Investor Conferences

August 27, 2025

From Disc Medicine Inc

Via GlobeNewswire

Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors

August 26, 2025

From Shattuck Labs, Inc.

Via GlobeNewswire

Disc Medicine (IRON) Q2 Loss Widens 109% ↗

August 07, 2025

Via The Motley Fool

Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update

August 07, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025

July 21, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Appoints Nadim Ahmed to its Board of Directors

July 14, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress

June 12, 2025

From Disc Medicine Inc

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.